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Objective: Toll-like receptors (TLRs) play a pivotal role in the homeostatic microflora-
host crosstalk. TLR4-mediated modulation of both motility and enteric neuronal survival
has been reported mainly for colon with limited information on the role of TLR4 in tuning
structural and functional integrity of enteric nervous system (ENS) and in controlling small
bowel motility.
Methods: Male TLR4 knockout (TLR4−/−, 9 ± 1 weeks old) and sex- and age-
matched wild-type (WT) C57BL/6J mice were used for the experiments. Alterations in
ENS morphology and neurochemical code were assessed by immunohistochemistry
whereas neuromuscular function was evaluated by isometric mechanical activity
of ileal preparations following receptor and non-receptor-mediated stimuli and by
gastrointestinal transit.
Results: The absence of TLR4 induced gliosis and reduced the total number of
neurons, mainly nNOS+ neurons, in ileal myenteric plexus. Furthermore, a lower
cholinergic excitatory response with an increased inhibitory neurotransmission was
found together with a delayed gastrointestinal transit. These changes were dependent
on increased ileal non-adrenergic non-cholinergic (NANC) relaxations mediated by a
complex neuronal-glia signaling constituted by P2X7 and P2Y1 receptors, and NO
produced by nNOS and iNOS.
Conclusion: We provide novel evidence that TLR4 signaling is involved in the fine-
tuning of P2 receptors controlling ileal contractility, ENS cell distribution, and inhibitory
NANC neurotransmission via the combined action of NO and adenosine-5′-triphosphate
(ATP). For the first time, this study implicates TLR4 at regulating the crosstalk between
glia and neurons in small intestine and helps to define its role in gastrointestinal motor
abnormalities during dysbiosis.
Keywords: toll-like receptor 4, enteric nervous system, small bowel, intestinal motility, intestinal transit, innate
immunity, gut microbiota, knockout mice
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INTRODUCTION
The functional link between endogenous gut microbes and their
host regulates the balance between commensalism and parasitism
on the microbial side, and between infection and resistance on the
host side. Although this complex bidirectional communication
is still not fully understood, it may be involved in the onset
of gastrointestinal functional disorders (GFD), such as irritable
bowel syndrome (IBS) (Barbara et al., 2016).
Commensal enteric microbiota efficiently influences innate
defenses by preventing pathogenic bacteria from crossing the
mucosal barrier (Kamada et al., 2013). However, this delicate
balance can be perturbed by several factors (e.g., stress, drugs,
and inflammation) leading to GFD as a result of a vicious cycle
in which host dysfunctions affect microflora environment leading
to dysbiosis and vice versa (Rakoff-Nahoum et al., 2004; Lee and
Lee, 2014). These disorders are characterized by intestinal barrier
breakdown, bacterial translocation and changes in motility
(Bischoff et al., 2014), and appear to be driven by abnormal
responses to microbiota-derived molecules via stimulation of
Toll-like receptors (TLRs) (Rakoff-Nahoum et al., 2004; Barbara
et al., 2016).
The finding of TLRs expressed in both central and enteric
nervous systems (CNS and ENS) (Barajon et al., 2009; Okun
et al., 2011), acting as key sensors not only for damage-associated
molecular patterns but also for physiological factors, strongly
extends the impact of TLRs in the nervous system beyond
their role in controlling host immune responses (Okun et al.,
2011). In other words, in absence of any underlying immune
response, the location in the nervous system of TLRs and
their activation by endogenous ligands underlies their role as
key players in regulating neurodevelopment and neuroplasticity
(Aravalli et al., 2007; Okun et al., 2011). Among all TLRs,
TLR4 is the best characterized pathogen-recognition receptor and
recently recognized to modulate ENS phenotype and function
(Anitha et al., 2012). We recently showed the expression of
TLR4 mRNA transcripts in freshly isolated smooth muscle cells
and enteric glial cells (EGCs) but not in resident macrophages
and dendritic cells (Brun et al., 2015). In vivo, under steady-
state conditions, TLR4 is generally absent or detected in very
small amounts in intestinal epithelial cells and in immune cells
located in the subepithelial lamina propria, in order to avoid
inappropriate activation despite the omnipresent microbiota
(Cario, 2010).
Several studies advocate for a role of TLRs in ENS homeostasis
(Kabouridis and Pachnis, 2015). TLR2−/− mice show disrupted
ENS structural and functional integrity, similar to that observed
in antibiotic-induced microbiota depleted wild-type mice
(Brun et al., 2013). Germ-free, antibiotic-treated mice and
TLR4 signaling-defective (Tlr4Lps−d) mice show similar
colonic dysmotility and fewer nNOS+ neurons (Anitha et al.,
2012). Furthermore, treatment with low lipopolysaccharide
(LPS) levels promotes the survival of cultured enteric
neurons in an NF-κB–dependent mechanism (Anitha et al.,
2012).
Based on these evidences, we sought to characterize the
role of TLR4 in tuning structural and functional integrity of
ENS and in controlling small bowel contractility for identifying
the signaling pathways involved in neuroimmune cross talk,
hopefully translatable into novel therapeutic strategies for
patients with GFD.
MATERIALS AND METHODS
Animals
Male TLR4−/− (B6.B10ScN-Tlr4lps−del/JthJ; 9 ± 1 weeks
old) and sex- and age-matched wild-type (WT) C57BL/6J
mice (Jackson Laboratories, Bar Harbor, ME, United States)
were housed in individually ventilated cages (IVC) at the
animal facility of the Department of Pharmaceutical and
Pharmacological Sciences, University of Padova. To normalize
gut microbiota, mice colonies from both groups were housed in
the same room and generally in the same cages, and maintained
by the same personnel. All animals were specific pathogen-
free and given standard chow diet and tap water ad libitum.
All experimental protocols were approved by the Animal Care
and Use Ethics Committee, University of Padova and Italian
Ministry of Health (authorization number: 1142/2015-PR) and
are reported in compliance with ARRIVE guidelines (McGrath
and Lilley, 2015).
Histology
Ileal specimens, fixed in 10% buffered formalin, embedded
in paraffin and cut into 4 µm-sections were stained with
haematoxylin and eosin (H&E) (Dall’Olmo et al., 2014). Ten
slides for each genotype were analyzed blindly.
Intestinal Paracellular Permeability
Intestinal paracellular permeability was assessed as previously
described (Aubé et al., 2006). Briefly, WT and TLR4−/− mice
were gavaged orally with absorbable fluorescein isothiocyanate
(FITC)-dextran (4 kDa molecular weight; 200 µl, 600 mg/kg
body weight). Preliminary experiments at various time points
(0, 0.5, 1, 2, 4, and 6 h) showed that the appearance
in blood of low molecular weight FITC-dextran peaked at
4 h following oral administration in WT and TLR4−/−
mice. After 4 h, FITC-dextran serum concentration was
determined using a fluorimeter (PerkinElmer, Milan, Italy) at
490/530 nm.
Gastrointestinal Transit
WT and TLR4−/− mice were gavaged orally with 70-kDa
FITC-dextran (25 mg/ml in 0.9% saline solution). Preliminary
experiments at various time points (0, 30, 45, 60, 75, and
90 min) showed that the distribution of high molecular weight
FITC-dextran peaked at 30 min in the ileum following oral
administration in WT and TLR4−/− mice. After 30 min, the
stomach and caecum were examined separately while small
intestine and colon were divided into 10 and 3 comparable
length-segments, respectively. Gastrointestinal transit was
determined using the intestinal geometric center of FITC-
dextran distribution throughout the intestine as described
previously (Aubé et al., 2006; Brun et al., 2013). Gastric emptying
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was determined by percentage of fluorescent probe that emptied
the stomach (Aubé et al., 2006).
Pellet Frequency and Fecal Water
Content
Fecal pellet output was assessed daily as previously described.
Mice were observed for 60 min. Fecal pellet numbers, fecal
wet weights and dry weights were determined. The difference
between wet and dry weights was used to calculate fecal water
content (McQuade et al., 2016).
In Vitro Contractility Studies
Contractility studies were performed as previously described
(Giron et al., 2008; Brun et al., 2013; Zoppellaro et al., 2013).
Briefly, 1-cm longitudinal segments from the distal ileum
were mounted in 10-mL-organ baths equilibrated for 30 min
in Krebs solution (37◦C). Changes in muscle tension were
recorded by isometric transducers connected to a PowerLab4/30
system (ADInstruments, Oxford, United Kingdom). Carbachol
(0.001–100 µM) and ADP (0.001–1 mM) dose-response curves
were obtained cumulatively. Non-receptor-mediated contractile
responses to 60 mM KCl were assessed. Neuronal-mediated
contractions were analyzed following electrical field stimulation
(EFS; 0–40 Hz; 40 V) in basal conditions or in non-adrenergic
non-cholinergic (NANC) conditions, obtained by adding 1 µM
guanethidine and 1 µM atropine to the organ bath. 10 Hz-
EFS-mediated NANC responses were evaluated in presence of
the pan-NOS inhibitor L-NAME (100 µM), the iNOS inhibitor
1400W (10 µM), the P1-purinoceptor antagonist theophylline
(100 µM), the P2-purinoceptor antagonist suramin (100 µM),
the P2Y1 receptor (P2Y1R) antagonist MRS2500 (1 µM) or the
P2X7R antagonist A804598 (0.1 µM).
Ten hertz-EFS-mediated tachykininergic responses were
recorded in NANC conditions with 100 µM L-NAME.
Contractile responses were expressed as gram tension/gram dry
tissue weight of ileal segments. Ileal relaxation was calculated
as the percentage reversal of the initial gram tension/dry tissue
weight, setting 100% inhibition as the maximum relaxation
(Zizzo et al., 2003).
Acetylcholine Esterase and
NADPH-Diaphorase Biochemical
Staining
Distal ileal 10 cm-segments were filled with fixative solution
(4% paraformaldehyde in PBS) for 1 h at room temperature.
Using a dissecting microscope, whole mount specimens of
longitudinal muscle-myenteric plexus (LMMP) were prepared as
previously described (De Mello et al., 2009; Brun et al., 2013).
Briefly, LMMP preparations were gently stretched and pinned
down on a wax support and subjected to acetylcholine esterase
(AChE) or NADPH-diaphorase (NADPHd) biochemical staining
(Anitha et al., 2006). Stained tissues mounted on glass slides
were observed using a Leica DMI4000 B microscope (Leica
Microsystems GmbH, Wetzlar, Germany). AChE+ myenteric
fibers and NADPHd+ neuronal cells analysis was performed
blindly by counting fibers or neurons in 10 randomly-chosen
images per mouse (six animals/group), as previously described
(De Mello et al., 2009).
Immunohistochemistry
Longitudinal muscle-myenteric plexus whole mount
preparations were gently stretched and pinned down on a
wax support and permeabilized in PBT (PBS with 0.3% Triton
X-100) and blocked with 2% bovine serum albumin (BSA)
for 1 h at room temperature, as previously reported (Brun
et al., 2013). Distal ileum (0.5 cm-segments) were frozen
in optimal cutting temperature mounting medium (OCT),
sectioned (7 µm-thick) with a cryostat (Leica CM 1850 UV,
Milan, Italy) and then mounted onto Superfrost Plus slides.
From each ileal specimen, 100 sequential 7 µm-cross-sections
were cut on a cryostat and 6–8 sections were subjected to
immunohistochemistry as previously described (Giron et al.,
2008; Zoppellaro et al., 2013). LMMP whole mount preparations
or ileal cryosections were then incubated overnight at room
temperature with the following antibodies: chicken polyclonal
anti-mouse glial fibrillary acidic protein (GFAP; 1:100; Abcam,
Milan, Italy), rabbit polyclonal anti-human GFAP (1:200; Merck
Millipore Corporation, Milan, Italy), mouse biotin-conjugated
anti-human HuC/D (1:50; Thermo Fisher Scientific, Milan,
Italy), rabbit polyclonal anti-mouse neuronal nitric oxide
synthase (nNOS, 1:100; Thermo Fisher Scientific, Milan, Italy),
rabbit polyclonal anti-human inducible NOS (iNOS; 1:50,
Santa Cruz Biotechnology, Milan, Italy), rabbit polyclonal
anti-human vasoactive intestinal peptide (VIP, 1:100; GenWay
Biotech, Milan, Italy), rabbit polyclonal anti-human P2X7
receptor-ATTO-488 (1:100; Alomone labs, Jerusalem, Israel),
rabbit polyclonal anti-human P2Y1 receptor (1:100; Alomone
labs, Jerusalem, Israel), rabbit monoclonal anti-human S100β
(1:100; Merck Millipore Corporation, Milan, Italy) and guinea
pig polyclonal anti-mouse substance P (1:100; Abcam, Milan,
Italy). Then cryosections or LMMP whole mount preparations
were washed and incubated for 2 h at room temperature with
the following secondary antibodies: Alexa Fluor 488-conjugated
goat anti-chicken IgG (1:1000; Thermo Fisher Scientific, Milan,
Italy), Alexa Fluor 488-conjugated goat anti-guinea pig IgG
(1:500; Thermo Fisher Scientific, Milan, Italy), Alexa Fluor
488-conjugated goat anti-rabbit IgG (1:1000; Thermo Fisher
Scientific, Milan, Italy), DyLight 649-conjugated goat anti-rabbit
IgG (1:500, Jackson ImmunoResearch Laboratories, Milan,
Italy) or Alexa Fluor 555-conjugated streptavidin (1:1000,
Thermo Fisher Scientific, Milan, Italy). Nuclei were stained
with TOTO-3 (1:500; Thermo Fisher Scientific, Milan, Italy) or
with 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI)
(1:1000; Thermo Fisher Scientific, Milan, Italy) added together
with the secondary antibodies. After three washes, LMMP whole
mount preparations or cryosections were mounted on glass
slides using a Mowiol Mounting Medium (100-mM Tris-HCl
(pH 8.5), 9% Mowiol 4–88, 25% glycerol and 0.1% DABCO).
Negative controls were obtained by incubating sections with
isotype-matched control antibodies at the same concentration as
primary antibody and/or pre-incubating each antibody with the
corresponding control peptide (final concentration as indicated
by manufacturer’s instructions) (Brun et al., 2013).
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Confocal Image Acquisition and Analysis
Images were acquired using a Nikon D-Eclipse C1 confocal
microscope (Nikon Instruments, Florence, Italy), equipped with
an oil-immersion Nikon Plan-Apo 60×/1.4 objective or a low-
magnification Nikon Plan Fluor 20×/0.5 objective. Five Z-series
images (10 planes for ileum cryosections or 15 planes for LMMP
whole mount preparations) of 1024 pixels × 1024 pixels were
processed as maximum intensity projections. All microscope
settings were kept constant for all images. Fluorescence intensity
of S100β, substance P, P2X7 receptors, P2Y1 receptors and
iNOS was assessed for each antigen in 20 images per mouse
(N = 5 mice/group), as previously reported (Arqués et al., 2014).
The obtained fluorescence values indicating the fluorescence
intensity of each protein of interest (i.e., S100β, substance P,
P2X7 receptors, P2Y1 receptors or iNOS) were normalized for
the fluorescence intensity of its own TOTO-3 or DAPI and were
reported as mean ± SEM, as previously described (Orso et al.,
2005).
Fluorescence intensity of GFAP+ fibers was determined by
applying the skeleton analysis method developed to quantify
brain microglia morphology as previously described (Morrison
et al., 2013). Briefly, for skeleton analysis, the maximum intensity
projection of the GFAP+ channel was enhanced to image
all enteric glial processes, followed by noise de-speckling to
eliminate single-pixel background fluorescence. After converting
the resulting images to binary, they were skeletonized using
ImageJ software and then analyzed by the AnalyzeSkeleton plugin
to determine the number of endpoints per frame and process
length. These data were normalized to a total area of 13.14 mm2,
obtained from 20 images per mouse (N = 5 mice/group) in
order to assess changes in EGCs. Analyses of images and related
fluorescence intensity were performed using ImageJ software
(Fiji, version 1.51n).
In ileal LMMP whole mount preparations, total neuron
population analysis was performed by counting HuC/D+ cells in
10 randomly-chosen images per mouse (N = 8 mice/group). The
total number of HuC/D+ neurons was recorded in each image
and normalized to the total area of 4.05 mm2. To evaluate the
distribution of nitrergic and VIPergic neurons in ileal myenteric
plexus, the number of nNOS+ and VIP+ enteric neurons was
blindly counted in 10 randomly-chosen images per mouse (N = 8
mice/group) and normalized to the total area of 4.05 mm2.
Chemicals
Unless otherwise specified, all chemicals were obtained
from Sigma–Aldrich (Milan, Italy) and were of the highest
commercially available analytical grade. OCT was purchased
from Kaltek (Padua, Italy), PFA was from Electron Microscopy
Sciences-Società Italiana Chimici (Rome, Italy), β-NADPH was
obtained from Diagnostic Brokers Associated (Milan, Italy), and
Triton-X-100 was from Applichem (Milan, Italy).
Statistical Analysis
All data are expressed as mean ± SEM. Differences between
the experimental groups were assessed using paired or unpaired
Student’s t-test and one-way or two-way analysis of variance
(ANOVA), followed by post hoc Bonferroni test. Data were
analyzed using GraphPad Prism 3.03 (San Diego, CA, United
States). The results were considered statistically significant at
p < 0.05; “N” values indicate the number of animals.
RESULTS
TLR4 Influences Ileal Morphology and
ENS Architecture
Since TLR4 expression is required for normal growth (including
villus height) of the small intestine (Riehl et al., 2015), we
sought to determine whether the absence of TLR4 influences
structural architecture by examining hematoxylin and eosin-
stained sections. In agreement with previous findings (Riehl et al.,
2015), TLR4−/− ileal morphology was comparable to WT, except
for villi height, which was significantly diminished (349 ± 9 µm
in WT mice vs. 306 ± 15 µm in TLR4−/− mice; N = 20
animals/group). No significant differences in serum levels of
absorbable FITC-dextran were found between TLR4−/− and WT
mice (0.42 ± 0.1 µg/ml and 0.32 ± 0.1 µg/ml, respectively;
N = 12 animals/group), to indicate no alterations in intestinal
permeability. Considering that TLR4 is expressed in ENS (Rumio
et al., 2006; Barajon et al., 2009), the impact of TLR4 absence
on ENS integrity was evaluated by immunohistochemistry. In
ileal cryosections, a 1.84-fold increase in the immunoreactivity of
the glial marker S100β was found in TLR4−/− myenteric plexus
(Figures 1A,B). These increases in S100β immunoreactivity were
associated to a 3.1-fold increase in process length of GFAP+
gliofilaments in TLR4−/− ENS (Figures 1C–E).
Absence of TLR4 Impairs
Gastrointestinal Motility
Previous studies have shown a reduced gastrointestinal transit 4 h
after non-absorbable FITC-dextran administration in C3H/HeJ
mice with a spontaneous point mutation in Tlr4 gene (Tlr4Lps−d)
(Anitha et al., 2012). We hypothesized that the same functional
impairment could be present in TLR4−/− mice (B6.B10ScN-
Tlr4lps−del), which are homozygous for a null mutation of Tlr4
gene.
In WT mice, the non-absorbable FITC-dextran transited
through the gastrointestinal tract over a 30-min period and
localized at the terminal ileum (Figure 2A). Conversely, a
significant reduction of geometric center and gastric emptying
was observed in TLR4−/− mice (Figures 2B,C). The number of
fecal pellets/hour and stool water content were significantly lower
in TLR4−/− mice compared to WT mice (Figures 2D,E).
TLR4 Deficiency Affects Excitatory
Neurotransmission
Based on the delayed gastrointestinal transit, we assessed
spontaneous contractility that resulted comparable in frequency
and amplitude in both genotypes (Figures 3A,B). To evaluate
excitatory responses, cumulative concentration-response curves
to the non-selective cholinergic receptor agonist, carbachol
(CCh) were performed. Ileal segments from TLR4−/− mice
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FIGURE 1 | TLR4 deficiency alters glial phenotype. Representative confocal microphotographs (A) of HuC/D (red) and S100β (green) distribution in wild-type (WT)
and TLR4−/− cryosections and quantification (B) of S100β fluorescence intensity (bars = 22 µm). (C) Representative confocal microphotographs of glial fibrillary
acidic protein (GFAP) distribution in WT and TLR4−/− cryosections (bars = 75 µm). (D) Representative confocal maximum intensity projection of GFAP+ channel
with the corresponding skeleton images. (E) Number of GFAP+ glial processes. Cell nuclei were stained with TOTO-3 (blue). ∗P < 0.05, ∗∗∗P < 0.001 vs. WT (N = 5
mice/group). LM, longitudinal muscle; CM, circular muscle; MG, myenteric ganglia; ML, mucosal layer.
showed a significant downward shift of the concentration-
response curve to CCh and a significant related decrease in the
maximum response compared to WT (Emax = −25.6 ± 7.5%;
Figure 3C). However, the response to high potassium-induced
depolarization was similar in both genotypes (Figure 3D).
Since ENS structural abnormalities have been described
in Tlr4Lps−d mice (Anitha et al., 2012), we sought to
test neuromuscular function by analyzing frequency-response
curves to EFS. Altered neurotransmission in TLR4−/− ileal
segments was reflected by reduced EFS-elicited contractions (by
28.5± 9.7% at 10 Hz, Figure 4A). The EFS-induced contractions
up to 10 Hz were of neuronal cholinergic origin as confirmed
by their sensitivity to tetrodotoxin (TTX) and to the muscarinic
receptor blocker atropine, as previously shown (Brun et al., 2013).
However, no changes in the number of AChE+ fibers were found
in TLR4−/− whole-mount preparations (Figures 4B,C).
To evaluate the contribution of other excitatory
neurotransmitters besides acetylcholine, we evaluated the
post-stimulus excitatory responses in NANC conditions, which
are determined by tachykininergic neurotransmission (Lecci,
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FIGURE 2 | TLR4 signaling influences gastrointestinal transit and gastric
emptying. (A) Percentage of non-absorbable fluorescein isothiocyanate
(FITC)-dextran distribution along the gastrointestinal tract (stomach, Sto; small
bowel, Sb 1–10; caecum, Cec; and colon, Col 1–3), (B) geometric center, (C)
percentage of gastric emptying, (D) pellet frequency per hour, (E) fecal water
content in WT and TLR4−/− mice. ∗P < 0.05, ∗∗P < 0.01 vs. WT (N = 12
mice/group).
2002). In WT mice, NANC responses evoked by EFS determined
a transient relaxation of ileal preparations, followed by TTX-
sensitive excitatory responses (Figures 5A,B) (Zizzo et al.,
2003). These excitatory responses were significantly reduced in
TLR4−/− ileal segments (by 30 ± 8.3%; Figures 5A,B). Upon
addition of L-NAME, a tachykinin-mediated excitatory response
(Lecci, 2002) was found in TLR4−/− preparations comparable to
WT (Figure 5C). Accordingly, no differences were observed in
the immunofluorescence distribution of substance P (SP) in WT
and TLR4−/− frozen sections (Figure 5D).
TLR4 Modulates Inhibitory
Neurotransmission
Considering that nitrergic neurotransmission (Zizzo et al., 2004;
Lomax et al., 2010), the primary inhibitory pathway in the
gut, is affected by dysbiosis (Kabouridis and Pachnis, 2015),
we tested whether the reduced excitatory contraction could
be the result of an increase of the inhibitory component.
Consistent with this prediction, a reduction of nitrergic neurons
stained with NADPH diaphorase (NADPHd) or anti-nNOS
was observed in TLR4−/− preparations (Figure 6). These
changes were accompanied by a significant reduction of the
total number of HuC/D+ neurons in TLR4−/− myenteric
plexus (Figures 6C–E). The reduction in nNOS+ neurons was
associated with a proportional increase of VIP+ neurons in
TLR4−/− mice (Figure 6).
In NANC conditions EFS at 10 Hz caused a 1.48-fold increase
in relaxation in TLR4−/− mice (Figure 7A). Pretreatment with
1400W, a selective inhibitor of iNOS, significantly reduced the
NANC-mediated relaxation in TLR4−/− mice (by 25.2 ± 0.5%,
Figure 7A), whereas a slight but not significant relaxation
(13.8 ± 0.9%, Figure 7A) was recorded in WT. These findings
support an involvement of iNOS in NO-mediated relaxation
in the absence of TLR4. Furthermore, iNOS immunoreactivity
increased by 5.7-fold in TLR4−/− myenteric neurons and
EGCs compared to WT (Figures 7B,C). Pretreatment with the
pan-NOS inhibitor L-NAME almost completely blocked EFS-
evoked NANC relaxation in WT mice. Conversely, in TLR4−/−
mice, this response was only partially abolished by L-NAME
(Figure 7A) suggesting an influence of TLR4 in nitrergic-
mediated relaxation and possibly in other inhibitory pathways
(e.g., purinergic or VIPergic), known to sustain intestinal
contractility (Zizzo et al., 2004). Accordingly, we evaluated
the role of adenosine and adenosine-5′-triphosphate (ATP) in
modulating relaxation in NANC conditions. Pretreatment with
L-NAME and theophylline, a non-selective adenosine receptor
antagonist, partially reduced the amplitudes of NANC-mediated
relaxation in both genotypes whereas the addition of L-NAME
and suramin, a non-selective ATP receptor antagonist, resulted in
a significant reduction of the inhibitory response (by 75.3± 1.5%,
Figure 7D) in TLR4−/− mice, reaching a relaxation amplitude
comparable to WT.
TLR4 Absence Affects Purinergic
Inhibitory Neurotransmission
Considering that inhibitory neurotransmission in TLR4−/−mice
depends on both nitrergic and ATP-mediated relaxation, we
evaluated the modulatory effect of ADP, the endogenous agonist
of P2Y1 receptors (P2Y1Rs). TLR4−/− mice showed a 1.43-fold
increase in relaxation amplitude following addition of ADP in
the organ bath with a significant shift to the left of the dose-
response curve to ADP compared to WT mice (Figure 8A).
Since also enteric P2X7 receptors (P2X7Rs) respond to ATP
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FIGURE 3 | TLR4 deficiency impairs contractile responses to carbachol but not to high KCl. Frequency (A) and amplitude (B) of spontaneous contraction in WT and
TLR4−/− ileal preparations (N = 15 mice/group). Concentration–response curves to carbachol (CCh, C) and KCl-mediated excitatory response (D) in WT and
TLR4−/− preparations (N = 8 mice/group). ∗P < 0.05 vs. WT.
by mediating inhibitory neurotransmission and are involved
in neuronal death during intestinal inflammation (Antonioli
et al., 2014; Brown et al., 2015), we examined the influence
of P2Y1Rs and P2X7Rs in NANC-mediated relaxation in the
absence of TLR4. In ileal tissues from TLR4−/− mice, P2Y1Rs
blockade with MRS2500 in presence of L-NAME markedly
reduced the amplitudes of NANC-mediated relaxation (by
45.1 ± 3%) whereas the addition of A804598 (a selective P2X7Rs
antagonist) determined a reduction of the inhibitory response
(by 24.2 ± 1.5%, Figure 8B), suggesting an involvement of both
receptors in modulating relaxation in NANC conditions in the
absence of TLR4.
Immunohistochemical analysis revealed a 1.79-fold increase
of P2Y1Rs staining in myenteric ganglia, in both neurons
and EGCs (Figure 9) and a 2.4-fold increase in P2X7Rs
immunoreactivity in TLR4−/− myenteric neurons, underlining
the involvement of TLR4 in ensuring ENS homeostasis
(Figure 10).
DISCUSSION
TLR4 plays a well-established regulatory role in the innate
immune response to infection and in adaptive responses
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FIGURE 4 | TLR4 deficiency alters ileal excitatory contractility. (A) EFS-induced excitatory responses in WT and TLR4−/− preparations (N = 8 mice/group).
Representative microphotographs showing the distribution (B) and % changes (C) of AChE+ fibers in WT and TLR4−/− preparations (N = 5 mice/group).
Bars = 200 µm. ∗P < 0.05 vs. WT.
consenting probiotic bacteria colonization. To date, several
studies have evaluated the role of TLR4 in gut mucosa, mainly
in colon, whereas only few have explored the impact of TLR4 in
the ENS of small intestine (Anitha et al., 2012; Kabouridis and
Pachnis, 2015).
Although polymorphisms in TLR4 gene affecting LPS
signaling have been described in patients with chronic
inflammatory bowel diseases (IBD), their pathophysiological
relevance in neuroimmune cross talk is still unclear (Cario,
2010). In this regard, ENS appears to be directly involved
in modulating the inflammatory response, since it express
several TLRs, including TLR4, in enteric neurons and glial cells
(Rumio et al., 2006; Sharkey and Savidge, 2014). In human
longitudinal muscle-myenteric plexus (LMMP) and in rat
ENS primary cultures, neural activation with EFS or ATP
has been shown to inhibit LPS-induced TNF-α production
through enteric neuronal P2X7R (Coquenlorge et al., 2014).
However, it is becoming clear that TLR4 overstimulation by
periodic intestinal infections, or its understimulation following
excessive use of antibiotics have the potential to affect the balance
between ENS-microbial-derived products early in life setting
the basis for developing GFD in adulthood (Becattini et al.,
2016).
Here, for the first time, we show the role of TLR4 on
ENS structural and functional integrity and provide relevant
insights into the underlying mechanisms. In particular, this study
demonstrates that the absence of TLR4 results in: (i) altered
distribution of the enteric glial markers GFAP and S100β; (ii)
decreased total number of HuC/D+ neurons; (iii) an altered
nNOS+-to-VIP+ neuron ratio; (iv) impaired tonic cholinergic
excitation; (v) enhanced inhibitory neurotransmission mediated
by the coordinated action of both NO (from nNOS and iNOS)
and ATP through the interaction with the purinergic P2X7Rs and
P2Y1Rs.
Previous immunohistochemical analyses have shown the
presence of TLR4 in gut neuromuscular layers, as well as in
sensory dorsal root ganglia, suggesting that both intrinsic and
extrinsic neuronal circuits possess the machinery to respond
directly to microbiota-derived stimuli (Barajon et al., 2009).
Indeed, our study showed that TLR4 deficiency does affect
the distribution of S100β and GFAP, specific markers for
EGCs (Gulbransen and Sharkey, 2012; Neunlist et al., 2014).
Recently, the role of EGCs has started to emerge not only
as a mechanical support for enteric neurons but as cellular
integrative bridge of gut homeostasis involved in controlling
neuroplasticity, mucosal barrier and inflammatory responses by
releasing specific gliomediators (e.g., NO, ATP) (Gulbransen
and Sharkey, 2012; Neunlist et al., 2014). Considering that
the pathophysiological functions of GFAP and S100β in the
ENS are still under discussion and that TLR4−/− mice
showed no changes in mucosal permeability and inflammatory
markers (as shown by us and others) (Peterson et al., 2010;
Devaraj et al., 2011), the increases in these regulatory and
structural proteins advocate for the presence of an underlying
gliopathy in absence of TLR4 signaling. In support of this
premise, increases in GFAP expression are associated with
EGCs differentiation, inflammation, and injury (Ochoa-Cortes
et al., 2016); S100β expression and release by ECGs at µM
levels are linked to pathological conditions (Rühl, 2005); and
EGCs gliosis, detected by increased GFAP levels and/or S100β
immunoreactivity/release, has been reported in ulcerative colitis,
microbial infection and neurodegenerative diseases (Ochoa-
Cortes et al., 2016).
Lipopolysaccharide hyporesponsiveness and delayed
gastrointestinal transit were reported for Tlr4Lps−d mice on
a C3H/HeJ background. However, our study was performed at
earlier time points (30 min vs. 4 h) following non-absorbable
FITC-dextran administration to evaluate the involvement
of the small intestine in the delayed transit. Although the
reduced pellet frequency and water content may resemble the
same colon dysmotility previously described in Tlr4Lps−d mice
(Anitha et al., 2012), our mouse model has a spontaneous
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FIGURE 5 | Tachykininergic neurotransmission is not affected by TLR4 deficiency. (A) Representative traces of contractile responses to increasing EFS frequencies
in WT and TLR4−/− segments under NANC conditions. (B) NANC responses evoked by EFS. (C) Tachykininergic nerve-evoked contractions induced by
10 Hz-EFS, in NANC condition with or without L-NAME in WT and TLR4−/− preparations (N = 8 mice/group). (D) Representative confocal microphotographs of
HuC/D (red) and substance P (green) distribution in WT and TLR4−/− cryosections. Cell nuclei were stained with TOTO-3 (blue; N = 5 mice/group). Bars = 22 µm.
LM, longitudinal muscle; CM, circular muscle; MG, myenteric ganglia; ML, mucosal layer. ∗P < 0.05 vs. WT.
mutation that results in a complete loss-of-function of TLR4,
whereas the Tlr4Lps−d mice have a point mutation causing
an amino acid substitution. In our study, no differences in
high potassium-induced contraction were revealed, suggesting
that TLR4 deficiency does not influence smooth muscle
function (Ratz et al., 2005). However, the downward shift
of the concentration-response curve to both carbachol and
EFS in TLR4−/− preparations may be explained by the
different contributing triggers to the onset of the reduced
excitatory neuromuscular response, such as impaired cholinergic
neurotransmission, higher level of inflammatory mediators
or enhanced inhibitory non-adrenergic non-cholinergic
transmission.
By expressing TLR4 and thus being sensitive to LPS,
enteric neurons appear to be involved in the regulation of
the innate tolerance response to microbial-derived products
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FIGURE 6 | TLR4 signaling modulates nitrergic and VIPergic neurotransmissions. Representative microphotographs showing the distribution (A) and density (B) of
NADPHd+ neurons in WT and TLR4−/− LMMP preparations (bars = 300 µm). Representative confocal microphotographs showing the distribution of nNOS (C;
green), VIP (D; green) and HuC/D (C,D; red) in WT and TLR4−/− LMMP preparations (bars = 22 µm). (E) Number of HuC/D+nNOS+, HuC/D+VIP+, and residual
HuC/D+ neurons in WT and TLR4−/− LMMP preparations (N = 8 mice/group). ∗P < 0.05, ∗∗∗P < 0.001 vs. WT.
in the intestine, ensuring a balanced immune response with
respect to luminal content. Both increased and decreased GI
motility have been reported after LPS exposure, depending
on the dose, timing between injection and assessments of
GI motility, the region of the GI system that is investigated
and the type of LPS (Bashashati et al., 2012). Low-grade
inflammation in the gut can alter digestive motility, through
changes in the functions of enteric nerves and/or smooth
muscle cells, thus highlighting a pathophysiological relationship
between bowel inflammation and abnormalities in enteric
motor activity (Kabouridis and Pachnis, 2015). However, recent
studies have detected no differences in the levels of several
inflammatory markers measured in serum and in peritoneal
macrophages in TLR4−/− animals compared to C57BL/6J
mice (Hritz et al., 2008; Zhang et al., 2008; Devaraj et al.,
2011).
Alterations in tachykininergic pathways have been shown in
GFD (Margolis and Gershon, 2009; Corsetti et al., 2015). Under
NANC conditions, post-stimulus excitatory responses with
L-NAME showed no differences between genotypes, consistent
with a lack of TLR4 involvement in tachykininergic pathways also
confirmed by immunohistochemistry of SP.
Since under certain conditions cholinergic nerve activity
can be depressed (Anitha et al., 2006), the observed marked
NANC-mediated relaxation indicates that impaired cholinergic
neurotransmission results from an enhanced inhibitory control
on cholinergic and noradrenergic transmission. The main
inhibitory neurotransmitter NO can be generated by the three
different enzymes, nNOS, eNOS, and iNOS. More than 90%
of the total NOS in the small intestine is nNOS, localized in
inhibitory neurons. However, iNOS isoform is also constitutively
present and accounts for less than 10% of the total enteric
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FIGURE 7 | TLR4 signaling modulates NO and P2 receptor-mediated relaxation. (A) 10 Hz-EFS-evoked NANC relaxation responses with or without 1400 W or
L-NAME in WT and TLR4−/− preparations (N = 8 mice/group). (B) Representative confocal microphotographs showing HuC/D (cyan), GFAP (magenta) and iNOS
(yellow) distribution (bars = 22 µm) and (C) analysis of changes in iNOS fluorescence intensity in WT and TLR4−/− LMMP preparations (N = 5 mice/group).
(D) 10 Hz-EFS-evoked NANC relaxation responses with or without L-NAME+theophylline or L-NAME+suramin in WT and TLR4−/− preparations (N = 8
mice/group).∗P < 0.05 vs. WT; ◦P < 0.05 vs. respective control without L-NAME; #P < 0.001 vs. respective control with L-NAME.
NOS activity whereas eNOS isoform is barely detectable (Lu
et al., 2006). In case of inflammation the induction of iNOS
produces a large amount of NO with consequent intestinal
dysmotility (Eskandari et al., 1999). NANC-mediated relaxation
was increased in TLR4−/− preparations and was mediated by NO
produced by iNOS and nNOS, whereas in WT mice the inhibitory
tone was mainly dependent on nNOS-derived NO. Moreover,
TLR4−/− myenteric ganglia contained a reduced number of
Frontiers in Pharmacology | www.frontiersin.org 11 June 2017 | Volume 8 | Article 350
fphar-08-00350 June 8, 2017 Time: 10:51 # 12
Caputi et al. TLR4 Modulates Enteric Inhibitory Neurotransmission
FIGURE 8 | Involvement of TLR4 signaling in purinergic neurotransmission. (A) Concentration-response curve to ADP in WT and TLR4−/− preparations (N = 8
mice/group). (B) 10 Hz-EFS-evoked NANC relaxation responses with or without L-NAME+MRS2500 (a P2Y1Rs antagonist) or L-NAME+A804598 (a P2X7Rs
antagonist) in WT and TLR4−/− preparations (N = 8 mice/group).∗P < 0.05 vs. WT; ◦P < 0.05 vs. respective control without L-NAME; #P < 0.001 vs. respective
control with L-NAME.
FIGURE 9 | TLR4 signaling influences P2Y1 receptor distribution. Representative confocal microphotographs showing (A) GFAP (magenta), P2Y1Rs (yellow) and
HuC/D (cyan) distribution and (B) analysis of P2Y1Rs fluorescence intensities in WT and TLR4−/− LMMP preparations (N = 5 mice/group). Cell nuclei were stained
with DAPI (gray). Bars = 22 µm. ∗P < 0.05 vs. WT.
HuC/D+ neurons, associated to a proportional reduction of
nNOS+ neurons in agreement with our functional findings
and as previously shown by Anitha et al. (2012) in whole
mount preparations. However, we found that this reduction in
nNOS+ neurons was accompanied with a proportional increase
of VIP+ neurons. VIP not only acts as a neurotransmitter
but also plays a role in neuroprotection and functions as
an anti-inflammatory agent (Ekblad and Bauer, 2004). These
adaptive changes in the proportion of VIP+ and nNOS+ neurons
with no modifications in SP-containing nerves appear to be
phenotypic characteristics of ENS resembling those found in
diabetic neuropathy (Voukali et al., 2011). At the functional
level, the loss of TLR4 appears to influence the nitrergic
pathway engaging other inhibitory transmitters responsible
for the increased NANC relaxations. Our findings of gliosis
and enhanced inhibitory tone, sensitive to both L-NAME and
suramin (a non-selective P2 receptor antagonist), support the
involvement of ATP in the ENS dysfunctions of TLR4−/−
mice.
ATP is known to play important roles in gut function as well
as in inflammation, since its P2 receptors are widely distributed
in neurons, glia, smooth muscle, and immune cells (Burnstock,
2014). In mouse ileum, pharmacological studies (Giaroni, 2002;
Gallego et al., 2014) have shown that in physiological conditions
ATP modulates relaxation by acting via P2Y1Rs, the main
receptor subtype mediating NANC inhibitory responses, partly
by direct action on smooth muscle and partly by activating
nNOS+ neurons that release ATP and NO. In the presence
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FIGURE 10 | TLR4 signaling influences P2X7 receptor distribution. Representative confocal microphotographs showing (A) HuC/D (magenta) and P2X7Rs (yellow)
distribution and (B) analysis of P2X7Rs fluorescence intensities in WT and TLR4−/− preparations (N = 5 mice/group). Cell nuclei were stained with TOTO-3 (blue).
Bars = 22 µm. ∗P < 0.05 vs. WT.
of inflammation, a overproduction of ATP activates the low
affinity P2X7Rs, contributing significantly to activating inhibitory
nitrergic neurons (Hu et al., 2001; Antonioli et al., 2014).
In this respect, it has been proposed that ATP released by
enteric neurons can activate EGCs, which in turn through Ca2+
signals and release of gliotransmitters (e.g., ATP, glutamate,
among others), communicate with other ECGs and neurons,
influencing gut contractility (Ochoa-Cortes et al., 2016). Here,
we found higher amplitude of relaxation to ADP (the P2Y1Rs
endogenous ligand) and NANC-mediated responses sensitive
to P2Y1 and P2X7 inhibition, together with an increase in
immunoreactivities of P2Y1Rs, P2X7Rs and iNOS in TLR4−/−
myenteric plexus. Our functional results support the notion that
TLR4 deficiency influences ATP neurotransmission, activating
myenteric P2X7Rs and P2Y1Rs and determining increased
smooth muscle relaxation and iNOS-derived NO production
potentially by enteric neurons and EGCs.
Recent studies so far have shown the involvement of TLR4
in the modulation of enteric neural stem/progenitor cells, and
of neural survival (Anitha et al., 2012; Schuster et al., 2014),
our work provides the first evidence of a cross-talk between
TLR4 and nitrergic/purinergic pathways in enteric neural-
glial communication (Rumio et al., 2006; Brown et al., 2015).
Specifically, our study advocates for a new scenario in the ENS,
where in the absence of TLR4, ATP pathways cooperate with
nitrergic neurotransmission through P2Y1Rs and P2X7Rs as
recently demonstrated by Brown et al. (2015).
CONCLUSION
Our study highlights for the first time a novel role for TLR4
in ileum, demonstrating that TLR4 fine-tunes ENS circuitry
modulating the inhibitory component of neuromotor activity
by NO and ATP co-transmission, essential for maintaining
a proper bidirectional neural-glial communication. Our findings
provides the basis for a better understanding of the mechanisms
underlying gastrointestinal dysmotility in presence of an
anomalous neuroimmune cross talk, thereby paving the way for
the development of suitable pharmacological modulators of TLR4
signaling for the management of GFD.
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